Background To systematically review and analyse the associations between fat and muscle
mass measures with overall survival in men with prostate cancer. Methods A systematic …

Purpose The increasing availability of clinical imaging tests (especially CT and MRI) that
directly quantify adipose tissue has led to a rapid increase in studies examining the …

Please see the Editorial Comment by James S. Jelinek discussing this article. CT-based
body composition measures are well established in research settings as prognostic markers …

This study will address the prevalence of pre-therapeutic sarcopenia (PS) and its clinical
impact during cancer treatment among adult cancer patients≥ 18 years of age. A meta …

Association between adiposity after diagnosis of prostate cancer and mortality: systematic
review and meta-analysis - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

Computed tomography (CT) scans used in treatment response assessment in prostate
cancer (PCa) patients are a useful tool for nutritional status evaluation. The aim of this study …

Obesity is a common risk factor in multiple tumor types, including prostate cancer. Obesity
has been associated with driving metastasis, therapeutic resistance, and increased …

Introduction Sarcopenia is common in men with metastatic castrate-resistant prostate cancer
(mCRPC) and has been largely assessed opportunistically through computed-tomography …

Abstract Background and Aims The incidence of frailty is increasing as the population ages,
which has important clinical implications given the associations between frailty and poor …

Background Low-skeletal muscle mass (LSMM) is defined as progressive skeletal muscle
loss, which can be assessed by imaging modalities. It was shown that this parameter is …